Holen Sie sich die Stockscreener-App
11.66
1.13%
0.13
Handel nachbörslich:
11.70
0.04
+0.34%
Schlusskurs vom Vortag:
$11.53
Offen:
$11.5
24-Stunden-Volumen:
2.51M
Relative Volume:
0.43
Marktkapitalisierung:
$8.62B
Einnahmen:
$158.30M
Nettoeinkommen (Verlust:
$4.74B
KGV:
-8.7015
EPS:
-1.34
Netto-Cashflow:
$-710.11M
1W Leistung:
+0.69%
1M Leistung:
+2.46%
6M Leistung:
+2.37%
1J Leistung:
+25.65%
1-Tages-Spanne:
$11.40
$11.67
1-Wochen-Bereich:
$11.40
$11.83
52-Wochen-Spanne:
$8.465
$13.05
Roivant Sciences Ltd Stock (ROIV) Company Profile
Firmenname
Roivant Sciences Ltd
Sektor
Branche
Telefon
441-295-5950
Adresse
CLARENDON HOUSE, 2 CHURCH STREET, HAMILTON HM11
Roivant Sciences Ltd Stock (ROIV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-02-15 | Eingeleitet | Wolfe Research | Outperform |
| 2024-01-05 | Eingeleitet | Piper Sandler | Overweight |
| 2023-12-12 | Eingeleitet | Deutsche Bank | Buy |
| 2023-10-17 | Eingeleitet | Guggenheim | Buy |
| 2023-06-08 | Eingeleitet | BofA Securities | Neutral |
| 2022-10-27 | Eingeleitet | JP Morgan | Overweight |
| 2022-05-23 | Eingeleitet | SVB Leerink | Outperform |
| 2022-04-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-12-15 | Eingeleitet | Goldman | Buy |
| 2021-11-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-28 | Eingeleitet | Citigroup | Buy |
| 2021-10-26 | Eingeleitet | Cowen | Outperform |
| 2021-10-26 | Eingeleitet | Jefferies | Buy |
| 2021-10-26 | Eingeleitet | Truist | Buy |
Alle ansehen
Roivant Sciences Ltd Aktie (ROIV) Neueste Nachrichten
Vanguard Group Inc's Strategic Acquisition in Roivant Sciences L - GuruFocus.com
Roivant Sciences (ROIV) Scheduled to Post Earnings on Tuesday - MarketBeat
Roivant Sciences Ltd. (NASDAQ:ROIV) Shares Bought by Impax Asset Management Group plc - MarketBeat
Allspring Global Investments Holdings LLC Sells 115,694 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat
Roivant to Report Financial Results for the Second Quarter Ended September 30, 2024 and Provide Business Update on Tuesday, November 12, 2024 - Yahoo Finance
Organon Completes Acquisition of Dermavant - njbmagazine.com
China Universal Asset Management Co. Ltd. Boosts Position in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat
Organon completes Dermavant Sciences acquisition By Investing.com - Investing.com Canada
Organon completes Dermavant Sciences acquisition - Investing.com
Organon Completes Acquisition of Dermavant, including Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1% - StockTitan
At Roivant Sciences, Eric Venker Chooses To Exercise Options, Resulting In $782K - Benzinga
Options Exercise: Eric Venker At Roivant Sciences Realizes $782K - Benzinga
Roivant Sciences Ltd. (NASDAQ:ROIV) COO Eric Venker Sells 100,000 Shares - MarketBeat
Roivant Sciences president sells $1.17 million in shares By Investing.com - Investing.com Australia
Roivant Sciences president sells $1.17 million in shares - Investing.com
Roivant Sciences: Good Value, But Near-Term Catalysts Could Bring Volatility (ROIV) - Seeking Alpha
Leerink maintains outperform on Roivant with steady target By Investing.com - Investing.com Australia
Roivant Sciences Ltd. (NASDAQ:ROIV) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Roivant Sciences (ROIV): High-Growth UK Stock with Innovative Drug Development Model - Insider Monkey
Exchange Traded Concepts LLC Makes New $2.27 Million Investment in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat
Roivant Sciences Ltd. (ROIV): Among the Most Promising Mid-Cap Stocks According to Hedge Funds - Insider Monkey
Dimensional Fund Advisors LP Buys Shares of 252,721 Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat
Why Roivant Sciences (ROIV) Is a Multibagger Stock to Watch - Substack
Handelsbanken Fonder AB Has $2.21 Million Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat
Roivant Sciences Ltd. (NASDAQ:ROIV) Shares Sold by The Manufacturers Life Insurance Company - MarketBeat
Is Roivant Sciences Ltd. (NASDAQ:ROIV) The Best NASDAQ Stock Under $20? - Insider Monkey
Roivant Sciences Ltd. (NASDAQ:ROIV) Shares Sold by Algert Global LLC - MarketBeat
Roivant Sciences Ltd. (NASDAQ:ROIV) Shares Acquired by Clearbridge Investments LLC - MarketBeat
Roivant Sciences Ltd. (NASDAQ:ROIV) Shares Bought by Thrivent Financial for Lutherans - MarketBeat
Biotech company nabs top two floors at Vornado’s Penn 1 - Yahoo Finance
Is Roivant Sciences Ltd. (ROIV) the Best Stock Under $15 To Buy Now? - Insider Monkey
Marshall Wace LLP Boosts Stock Position in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat
Is Roivant Sciences Ltd. (ROIV) a Strong Buy Amid Positive Clinical Trials and Strategic Partnerships? - Insider Monkey
Is Roivant Sciences Ltd. (NASDAQ:ROIV) The Best NASDAQ Stock Under $50 To Buy? - Insider Monkey
Roivant Sciences Ltd. (NASDAQ:ROIV) Stock Position Lifted by Pacer Advisors Inc. - MarketBeat
Roivant Sciences director sells over $5.8 million in company stock - Investing.com India
Roivant Sciences director sells over $5.8 million in company stock By Investing.com - Investing.com Australia
Roivant Sciences director Gold sells over $51 million in company stock - Investing.com
QVT Financial LP Adjusts Stake in Roivant Sciences Ltd - GuruFocus.com
Director Keith Manchester Sells 503,000 Shares of Roivant Sciences Ltd (ROIV) - GuruFocus.com
QVT Financial LP sells Roivant Sciences shares worth over $10 million By Investing.com - Investing.com South Africa
QVT Financial LP sells Roivant Sciences shares worth over $10 million - Investing.com Australia
Roivant Sciences Ltd. (NASDAQ:ROIV) Shares Acquired by DME Capital Management LP - MarketBeat
Vivek Ramaswamy Plots His Next Move, With or Without Trump - Bloomberg
Freshfields advises Roivant in sale of Dermavant to Organon - Legal Desire News Network
Finanzdaten der Roivant Sciences Ltd-Aktie (ROIV)
Umsatz
Nettogewinn
Free Cashflow
ENV
Roivant Sciences Ltd-Aktie (ROIV) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Venker Eric | President & COO |
Oct 21 '24 |
Sale |
11.65 |
100,000 |
1,165,000 |
617,470 |
2.02%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):